We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Hill

Michael D Hill MD, MSc, FRCPC

Calgary Stroke Program, Professor of Neurology, Heart & Stroke Foundation and HBI Professor Stroke Research Department of Clinical Neurosciences, Department of Community Health Sciences, Department of Radiology & Department of Medicine, Hotchkiss Brain Institute, University of Calgary, Cumming School of Medicine, Alberta, Calgary, Canada

Dr. Michael Hill is a Professor for the Departments of Clinical Neurosciences, Community Health Sciences, Medicine and Radiology at the University of Calgary.  He is also Director of the Stroke Unit for the Calgary Stroke Program, Alberta Health Services. 

Dr. Hill completed undergraduate training at McGill University in biochemistry and went on to the University of Ottawa medical school. He  trained in internal medicine at the University of Ottawa and received his FRCPC (Internal Medicine) in 1997. Subsequently, he completed a neurology residency at the University of Toronto and received his FRCPC (Neurology) in 1999. Dr. Hill moved to Calgary to undertake a stroke fellowship and clinical epidemiology training at the University of Calgary and was appointed to faculty in 2001.  He then completed his MSc thesis in 2003, and is currently Director of the Stroke Unit at the Foothills Medical Centre, Calgary Health Region. 

Dr. Hill’s research interests include stroke thrombolysis, stroke epidemiology, and surveillance and clinical trials.  He is funded by the Canadian Institutes for Health Research (CIHR) and holds the Heart & Stroke Foundation of Alberta/NWT/Nunavut professorship in Stroke Research. He holds and has held operating and clinical trials grants from the CIHR, Heart & Stroke Foundation of Alberta/NWT/Nunavut and from various industry partners as well as  NIH (NINDS). Dr. Hill has also received a number of awards, including the Barnett, The Pessin Award and the ARP merit award and the Performance Recognition award for his role in research and his outstanding publication record.

Disclosures

Dr. Hill is an employee of the University of Calgary.  Covidien provided an unrestricted grant to the University of Calgary to partially fund the ESCAPE trial.